Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that its resubmitted New Drug Application (NDA) for …

Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application Read More